Samuel G. Regalado

Samuel G. Regalado

Auto-generated profile, based on publicly available information

Samuel G. Regalado

Department of Genome Sciences, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2022 in Blood
Verified
Journal Article
Open access
PDF file
SCSeunga Choo
Seunga Choo
FLFranziska K. Lorbeer
Franziska K. Lorbeer
SRSamuel G. Regalado
Samuel G. Regalado
SSSarah B. Short
Sarah B. Short
SWShannon Wu
Shannon Wu
DHDirk Hockemeyer
Dirk Hockemeyer
Mutations in the TINF2 gene, encoding the shelterin protein TIN2, cause telomere shortening and the inherited bone marrow (BM) failure syndrome dyskeratosis congenita (DC). A lack of suitable model systems limits the mechanistic understanding of telomere shortening in the stem cells and thus hinders the development of treatment options for BM failure. Here, we endogenously introduced TIN2-DC mutations in human embryonic stem cells (hESCs) and human hematopoietic stem and progenitor cells (HSPCs) to dissect the disease mechanism and identify a gene-editing strategy that rescued the disease phenotypes. The hESCs with the T284R disease mutation exhibited the short telomere phenotype observed in DC patients. Yet, telomeres in mutant hESCs did not trigger DNA damage responses at telomeres or show exacerbated telomere shortening when differentiated into telomerase-negative cells. Disruption of the mutant TINF2 allele by introducing a frameshift mutation in exon 2 restored telomere length in stem cells and the replicative potential of differentiated cells. Similarly, we introduced TIN2-DC disease variants in human HSPCs to assess the changes in telomere length and proliferative capacity. Lastly, we showed that editing at exon 2 of TINF2 that restored telomere length in hESCs could be generated in TINF2-DC patient HSPCs. Our study demonstrates a simple genetic intervention that rescues the TIN2-DC disease phenotype in stem cells and provides a versatile platform to assess the efficacy of potential therapeutic approaches in vivo.

28 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
FCFlorence M. Chardon
Florence M. Chardon
TMTroy A. McDiarmid
Troy A. McDiarmid
NPNicholas F. Page
Nicholas F. Page
RDRiza M. Daza
Riza M. Daza
BMBeth Martin
Beth Martin
JSJay Shendure
Jay Shendure
CRISPR-based gene activation (CRISPRa) is a promising therapeutic approach for gene therapy, upregulating gene expression by targeting promoters or enhancers in a tissue/cell-type specific manner. Here, we describe an experimental framework that combines highly multiplexed perturbations with single-cell RNA sequencing (sc-RNA-seq) to identify cell-type-specific, CRISPRa-responsive cis- regulatory elements and the gene(s) they regulate. Random combinations of many gRNAs are introduced to each of many cells, which are then profiled and partitioned into test and control groups to test for effect(s) of CRISPRa perturbations of both enhancers and promoters on the expression of neighboring genes. Applying this method to a library of 493 gRNAs targeting candidate cis- regulatory elements in both K562 cells and iPSC-derived excitatory neurons, we identify gRNAs capable of specifically upregulating intended target genes and no other neighboring genes within 1 Mb, including gRNAs yielding upregulation of six autism spectrum disorder (ASD) and neurodevelopmental disorder (NDD) risk genes in neurons. A consistent pattern is that the responsiveness of individual enhancers to CRISPRa is restricted by cell type, implying a dependency on either chromatin landscape and/or additional trans- acting factors for successful gene activation. The approach outlined here may facilitate large-scale screens for gRNAs that activate therapeutically relevant genes in a cell type-specific manner.

5 November 2021 in bioRxiv
Verified
Preprint
Open access
JCJunhong Choi
Junhong Choi
WCWei Chen
Wei Chen
AMAnna Minkina
Anna Minkina
FCFlorence M. Chardon
Florence M. Chardon
CSChase C. Suiter
Chase C. Suiter
JSJay Shendure
Jay Shendure
DNA is naturally well-suited to serve as a digital medium for in vivo molecular recording. However, DNA-based memory devices described to date are constrained in terms of the number of distinct signals that can be concurrently recorded and/or by a failure to capture the precise order of recorded events 1 . Here we describe DNA Ticker Tape, a general system for in vivo molecular recording that largely overcomes these limitations. Blank DNA Ticker Tape consists of a tandem array of partial CRISPR-Cas9 target sites, with all but the first site truncated at their 5’ ends, and therefore inactive. Signals of interest are coupled to the expression of specific prime editing guide RNAs 2 . Editing events are insertional, and record the identity of the guide RNA mediating the insertion while also shifting the position of the “write head” by one unit along the tandem array, i.e. sequential genome editing. In this proof-of-concept of DNA Ticker Tape, we demonstrate the recording and decoding of complex event histories or short text messages; evaluate the performance of dozens of orthogonal tapes; and construct “long tape” potentially capable of recording the order of as many as 20 serial events. Finally, we demonstrate how DNA Ticker Tape simplifies the decoding of cell lineage histories.

3 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SSSophie Seidel
Sophie Seidel
AZAntoine Zwaans
Antoine Zwaans
SRSamuel Regalado
Samuel Regalado
JCJunhong Choi
Junhong Choi
JSJay Shendure
Jay Shendure
TSTanja Stadler
Tanja Stadler
CRISPR-based lineage tracing offers a promising avenue to decipher single cell lineage trees, especially in organisms that are challenging for microscopy. A recent advancement in this domain is lineage tracing based on sequential genome editing, which not only records genetic edits but also the order in which they occur. To capitalize on this enriched data, we introduce SciPhy, a simulation and inference tool integrated within the BEAST 2 framework. SciPhy utilizes a Bayesian phylogenetic approach to estimate time-scaled phylogenies and cell population parameters. After validating SciPhy using simulations, we apply it to two lineage tracing datasets for which we estimate time-scaled trees together with cell proliferation rates. Using simulated and real lineage tracing data obtained from a monoclonal culture of HEK293T cells, we compare SciPhy to other lineage reconstruction methods, and find that SciPhy consistently constructs distinct, and more accurate lineage trees. In particular, for HEK293T cells, SciPhy trees stand out for their later estimated cell division times. In addition, SciPhy reports uncertainty as well as proliferation rates, neither of which are available within a UPGMA analysis. Our second example applies SciPhy to the study of murine gastruloids, and showcases the use of complex models of time-varying population growth to capture realistic aspects of this in-vitro model of early mammalian development. Together, these examples showcase the application of advanced phylogenetic and phylodynamic tools to explore and quantify cell lineage trees, laying the groundwork for enhanced and confident analyses to decode the complexities of biological development in multicellular organisms. SciPhy’s codebase is publicly available at https://github.com/azwaans/SciPhy .

21 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
TLTony Li
Tony Li
JLJean-Benoît Lalanne
Jean-Benoît Lalanne
EKEmma A.N. Kajiwara
Emma A.N. Kajiwara
SJShruti Jain
Shruti Jain
XLXiaoyi Li
Xiaoyi Li
JSJay Shendure
Jay Shendure
Cis -regulatory elements (CREs) such as enhancers play a central role in orchestrating mammalian development, yet how they have gained, lost, maintained or changed function over the course of mammalian evolution remains poorly understood. To address this gap, we densely mapped the functional evolution of five mouse developmental enhancers by testing orthologous sequences from 480 extant and ancestrally reconstructed mammalian genomes (Zoonomia 1 , Cactus 2 ) with massively parallel reporter assays (MPRAs). This phylogenetic dissection revealed diverse modes of evolution, from lineage-restricted activity to deep functional conservation despite extensive sequence divergence. To pinpoint causal changes, we developed a model-driven reconstitution strategy that uses deep learning-based predictions of chromatin accessibility to re-introduce a succession of mutations into ancestral orthologs; this revealed critical transcription factor binding site (TFBS) changes and pervasive context-dependent epistasis, including instances where mutational effects were strongly contingent on the order of their introduction. When we extended this strategy to tune the activity of extant orthologs, we found that ablation of enhancer function required as few as one to seven mutations, whereas enhancement was constrained by element-specific activity ceilings—a striking asymmetry in the predictability of model-guided enhancer editing. Together, these results shed light on how the plasticity of mammalian enhancers intersects with their evolution, and advance a framework for reprogramming the activity of endogenous CREs at nucleotide resolution.